Madrigal Pharmaceuticals (NASDAQ:MDGL) and Viking Therapeutics (NASDAQ:VKTX) were among notable gainers on Thursday as Altimmune (NASDAQ:ALT) boosted its rivals after posting a mixed outcome from a ...
Altimmune stock: 48-week pemvidutide MASH data, FDA Breakthrough Therapy boost, but rising competition and cash needs. Click ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results